CEP
Chicago Equity Partners’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-102,125
| Closed | -$4.44M | – | 943 |
|
|
2019
Q2 | $4.44M | Buy |
102,125
+32,585
| +47% | +$1.42M | 0.2% | 129 |
|
|
2019
Q1 | $2.65M | Sell |
69,540
-20,720
| -23% | -$789K | 0.1% | 278 |
|
|
2018
Q4 | $3.88M | Sell |
90,260
-3,380
| -4% | -$145K | 0.16% | 179 |
|
|
2018
Q3 | $4.6M | Buy |
+93,640
| New | +$4.6M | 0.14% | 198 |
|
|
2017
Q3 | – | Sell |
-12,600
| Closed | -$601K | – | 798 |
|
|
2017
Q2 | $601K | Buy |
+12,600
| New | +$601K | 0.02% | 600 |
|
|
2014
Q4 | – | Sell |
-2,150
| Closed | -$208K | – | 444 |
|
|
2014
Q3 | $208K | Sell |
2,150
-150
| -7% | -$14.5K | 0.01% | 420 |
|
|
2014
Q2 | $211K | Buy |
+2,300
| New | +$211K | 0.01% | 411 |
|
|
2013
Q4 | – | Sell |
-4,450
| Closed | -$213K | – | 460 |
|
|
2013
Q3 | $213K | Buy |
+4,450
| New | +$213K | 0.01% | 410 |
|